PRESS RELEASE published on 09/04/2024 at 17:45, 2 months 18 days ago Q1 2024/25 REVENUE: EUR 94.0 MILLION, UP +0.7% - AERO ACTIVITIES CONTINUE TO GROW (+4.0%) DESPITE STILL DEMANDING ENVIRONMENT - 2024/25 FINANCIAL TARGETS MAINTAINED FIGEAC AÉRO reports €94.0M revenue for Q1 FY 2024/25 showing +0.7% YoY growth, driven by aerospace activities despite temporary setbacks. Market outlook remains positive with solid order books Revenue Market Outlook Aerospace FIGEAC AÉRO Order Books
BRIEF published on 07/31/2024 at 19:55, 3 months 22 days ago FIGEAC AÉRO Publishes its Annual Report as of March 31, 2024 Annual Report Finance 2024 FIGEAC AÉRO Aeronautics
BRIEF published on 07/18/2024 at 18:20, 4 months 4 days ago FIGEAC AÉRO Appoints an Administrator in Charge of CSR Sustainable Development CSR FIGEAC AÉRO PILOT 28 Aeronautics
PRESS RELEASE published on 07/18/2024 at 18:15, 4 months 4 days ago FIGEAC AÉRO'S BOARD OF DIRECTORS DESIGNATES A DIRECTOR OVERSEEING CSR FIGEAC AÉRO appoints Anne Tauby as CSR director, enhancing CSR governance. PILOT 28 strategy focuses on CSR & sustainable growth aligned with zero-carbon aviation goals by 2050 FIGEAC AÉRO Anne Tauby CSR Governance PILOT 28 Strategy Zero-carbon Aviation
BRIEF published on 07/03/2024 at 18:05, 4 months 19 days ago Half-yearly review of the FIGEAC AÉRO liquidity contract Liquidity Contract Transactions TP ICAP Actions FIGEAC AÉRO
BRIEF published on 06/26/2024 at 18:05, 4 months 26 days ago FIGEAC AÉRO exceeds its financial objectives for the third consecutive year Financial Results EBITDA Growth FIGEAC AÉRO Aeronautics
PRESS RELEASE published on 06/26/2024 at 18:00, 4 months 26 days ago 2023/24 FULL-YEAR RESULTS: FIGEAC AÉRO MEETS OR BEATS ALL ITS FINANCIAL TARGETS FOR THE THIRD CONSECUTIVE YEAR FIGEAC AÉRO releases strong full-year results for 2023/24: revenue surpassing target at €397.2M with +19.3% organic growth, EBITDA margin rising to 13.2%, free cash-flow exceeds target at €24.1M Revenue EBITDA Margin Organic Growth Full-year Results FIGEAC AÉRO
BRIEF published on 06/20/2024 at 17:50, 5 months 2 days ago FIGEAC AÉRO ORGANIZES A WEBINAR FOR INDIVIDUAL INVESTORS Investors Webinar Annual Results FIGEAC AÉRO Aeronautics
PRESS RELEASE published on 06/18/2024 at 18:05, 5 months 4 days ago PILOT 28: FIGEAC AÉRO AND KNDS FORTIFY THEIR PARTNERSHIP FIGEAC AÉRO signs new agreement with KNDS worth tens of millions at Eurosatory, reinforcing long-term partnership and locating strategic production in France Agreement France FIGEAC AÉRO KNDS Defence Production
BRIEF published on 06/18/2024 at 18:05, 5 months 4 days ago PILOT 28: FIGEAC AÉRO AND KNDS STRENGTHEN THEIR PARTNERSHIP Partnership FIGEAC AÉRO Defense Industry Détail KNDS
Published on 11/22/2024 at 23:55, 9 hours 12 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 9 hours 37 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 10 hours 2 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 10 hours 37 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 14 hours 52 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 15 hours 13 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 16 hours 11 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 17 hours 7 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 2 days 2 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 13 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 15 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 15 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024